3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
22
Lymphoma, Large B-Cell, Diffuse
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Follicular
12
Lymphoma
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Rhabdomyosarcoma
8
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, B-Cell
6
Leukemia, Biphenotypic, Acute
6
Wilms Tumor
5
Sarcoma, Ewing
5
Recurrence
5
Neuroblastoma
5
Neoplasms
5
Lymphoma, Non-Hodgkin
5
Lymphoma, T-Cell
4
Rhabdomyosarcoma, Embryonal
3
Medulloblastoma
3
Lymphoproliferative Disorders
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Down Syndrome
3
Sarcoma
2
Rhabdomyosarcoma, Alveolar
2
Rhabdoid Tumor
2
Plasmablastic Lymphoma
2
Osteosarcoma
2
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
amino-acid, glucose, and electrolyte solution
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Vincristine
×
90 days
×
Clear all
No trials found.